Chunming Ma

Dr. Chunming Ma

First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2016 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
YTYiming Tian
Yiming Tian
RWRui Wang
Rui Wang
LLLianyuan Liu
Lianyuan Liu
CMChunming Ma
Chunming Ma
QLQiang Lu
Qiang Lu
FYFuzai Yin
Fuzai Yin
Zoledronic acid-induced uveitis (ZAIU) is rare but severe, and has been recently considered part of an acute phase reaction. Only 15 cases have been reported since 2005. Here we describe a case with macular edema, which is the first reported case observed after long-term alendronate tolerance. A 63-year-old Asian woman received her first intravenous zoledronic acid treatment for the management of postmenopausal osteoporosis as a more convenient substitute for oral alendronate. Twenty-four hours later, bilateral eye irritations, periorbital swelling, blurred vision, and diplopia presented. The complete blood count and transaminase levels were normal, but the erythrocytic sedimentation, C-reactive protein, and serum C4 levels were elevated. On detailed ophthalmological examination, a diagnosis of bilateral acute uveitis and macular edema in the right eye was made. The ocular symptoms were not improved until administration of topical and oral steroids. Complete resolution was achieved. There was no rechallenge of bisphosphonates, and no recurrence at 6 months follow-up. Based on an extensive review, abnormal fundus is rarely reported, especially in cases of macular edema. Rechallenge with zoledronic acid in five cases induced no additional uveitis, and changing the medication to pamidronate in another patient was also tolerated. Interestingly, our patient suffered from uveitis soon after intravenous zoledronate exposure after a two-year tolerance to oral alendronate. This is the first report of zoledronic acid induced uveitis with macular edema after long-term alendronate tolerance. Prior oral alendronate may not entirely prevent ZAIU. Steroids are usually necessary in the treatment of ZAIU. Bisphosphonate rechallenge is not fully contraindicated, and prior steroid administration may be a more reasonable treatment choice according to the available evidence.

27 March 2015 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
CMChunming Ma
Chunming Ma
XLXiao-Li Liu
Xiao-Li Liu
FYFu-Zai Yin
Fu-Zai Yin
GGGuo-Qin Gao
Guo-Qin Gao
RWRui Wang
Rui Wang
QLQiang Lu
Qiang Lu

1 April 2017 in Pediatrics & Neonatology
Verified
Journal Article
Open access
CMChunming Ma
Chunming Ma
FYFu-Zai Yin
Fu-Zai Yin
XLXiao-Li Liu
Xiao-Li Liu
RWRui Wang
Rui Wang
DLDong-Hui Lou
Dong-Hui Lou
QLQiang Lu
Qiang Lu
The present study demonstrates that the height-corrected definition of MS is a simple, inexpensive, and accurate tool for identifying MS in Han adolescents.

31 October 2010 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
QLQiang Lu
Qiang Lu
FYFu-Zai Yin
Fu-Zai Yin
CMChunming Ma
Chunming Ma
BLBo-Wei Liu
Bo-Wei Liu
DLDong-Hui Lou
Dong-Hui Lou
CQChun-Mei Qin
Chun-Mei Qin

1 April 2021
Verified
Journal Article
Closed access
MZMeng-Meng Zhang
Meng-Meng Zhang
MJMei-Jing Ji
Mei-Jing Ji
XWXiao-Ming Wang
Xiao-Ming Wang
SWSi-Qiong Wang
Si-Qiong Wang
JSJing Sun
Jing Sun
CMChunming Ma
Chunming Ma

9 October 2015 in Clinical and Experimental Hypertension
Verified
Journal Article
Closed access
CMChunming Ma
Chunming Ma
QLQiang Lu
Qiang Lu
FYFu-Zai Yin
Fu-Zai Yin
This study evaluated the accuracy of modified blood pressure-to-height ratio (MBPHR) for identifying hypertension in Han children aged 7-12 years.